Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
| Current Price | ₹128.05 |
|---|---|
| Market Cap | ₹132 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Laboratory Services |
| P/E Ratio | 2,561 |
| Return on Equity | 0.42% |
| 52-Week Range | ₹51.52 – ₹135.88 |
| Beta (1Y) | -0.62 |
1. Pathology and Diagnostics-100%
Aspira Pathlab & Diagnostics Lim is trading at ₹128.05, with a market capitalisation of ₹132 Cr.
Aspira Pathlab & Diagnostics Lim operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Laboratory Services).
Aspira Pathlab & Diagnostics Lim has a P/E of 2,561 and a return on equity of 0.42%.